Your session is about to expire
← Back to Search
Behavioural Intervention
Exergaming for Spinal Muscular Atrophy (INFORM SMA Trial)
N/A
Recruiting
Led By Danielle Levac
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Confirmed genetic diagnosis of 5q SMA
Participant is able to stay seated independently without support for at least 10 seconds
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 16 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if playing video games at home for 8 weeks can help children and youth with spinal muscular atrophy feel more satisfied with their daily activities compared to their usual care.
Who is the study for?
This trial is for children and adolescents aged 8-18 with spinal muscular atrophy (SMA) who can raise their hands to their mouth but not a light weight, are on disease-modifying therapy, have confirmed genetic SMA diagnosis, and can sit unaided for at least 10 seconds.
What is being tested?
The study compares an 8-week home-based exergaming program called Tales from the Magic Keep™ against usual care. It aims to see if this fun video game-like exercise can improve how satisfied kids with SMA feel about their daily activities.
What are the potential side effects?
Since the intervention involves playing an exergame designed for children with SMA, side effects might include typical exercise-related issues like muscle soreness or fatigue. However, specific side effects will depend on individual health conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a confirmed genetic diagnosis of 5q SMA.
Select...
I can sit by myself without support for at least 10 seconds.
Select...
I can move my hands to my mouth but can't lift a light weight to it.
Select...
I am between 8 and 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Satisfaction with occupational performance
Secondary study objectives
Independence performing activities of daily living
Self- reported fatigue
Upper limb motor activity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exergaming Intervention for 8 WeeksExperimental Treatment1 Intervention
Extension Phase: Participants randomized ot the intervention arm will play Tales from the Magic Keep at home for the 8 week open-label extension phase
Group II: Usual Care for 8 weeks.Active Control1 Intervention
Extension Phase: Participants randomized to waitlist usual care will play Tales from the Magic Keep at home for the 8 week open-label extension phase
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
470 Previous Clinical Trials
166,939 Total Patients Enrolled
Maryam Oskoui, MD, MSc, FRCPC, FAANLead Sponsor
Danielle LevacPrincipal InvestigatorUniversité de Montréal
Share this study with friends
Copy Link
Messenger